COVID-19

For two years, the world has been battling COVID-19 with masks, vaccines, and lockdowns. But countries have largely failed to channel their shared experiences into a blueprint for action.
Feb 4, 2022
For two years, the world has been battling COVID-19 with masks, vaccines, and lockdowns. But countries have largely failed to channel their shared experiences into a blueprint for action.
Feb 4, 2022
  • Monetary Policy
    What Is the U.S. Federal Reserve?
    Over the past decade, the Fed kept interest rates low while it deployed trillions of dollars in stimulus and expanded its regulatory oversight. Now, the central bank is back in the spotlight for its battle against inflation.
  • United States
    In-Person DC Roundtable: National Security and the U.S. Pharma and Biotech Industries
    Play
    The COVID-19 pandemic and chronic U.S. drug shortages highlight the health security and strategic importance of U.S. pharmaceutical and biotechnology capabilities during and between pathogenic crises. Geopolitical competition and interest in industrial policy for biotechnology further underscore the national security role of domestic biopharmaceutical infrastructure. Policymakers confront competing health, economic, and strategic priorities in maximizing innovation in technology, business models, and health-care systems in facilitating safe, accessible, secure, and sustainable products, services, and supply chains.   Please join our speakers, Monique K. Mansoura, executive director for global health security and biotechnology at The MITRE Corporation, and Victor Suarez, Colonel (ret.), U.S. Army, senior fellow (visiting) at The Council on Strategic Risks and founder of BluZoneBio, to explore challenges facing the U.S. pharma and biotech industries and approaches to strengthening the national security resilience of those industries in a world marked by health and geopolitical threats.
  • Global Health Program
    Hybrid DC Roundtable: The CDC Response to the Spread of H5N1 Avian Flu in Dairy Cows
    Play
    An outbreak of H5N1 avian influenza that was detected for the first time in a milking herd of cattle in Texas one month ago has now infected thirty-three herds in eight states and at least one farm worker, spurring alarm among some experts that human-to-human transmission could be next. Please join us for a discussion with Dr. Nirav D. Shah, Principal Deputy Director of the U.S Centers for Disease Control and Prevention, on the U.S. response to this avian flu outbreak and on how the CDC and its U.S. government counterparts are applying lessons from COVID-19 to respond to the potential threat.